Sutro Biopharma hires Hallam as CSO
This article was originally published in Scrip
Sutro Biopharma, a US-based biopharmaceutical company focused on the development and design of protein therapeutics, has appointed Dr Trevor Hallam chief scientific officer. He has more than 25 years' experience, having most recently served as executive vice-president of R&D and executive officer at Palatin Technologies. Before that, Dr. Hallam held several management positions at AstraZeneca.